SPTY2D1: Key Regulator of Cell Growth and Differentiation (G144108)

Target Name: SPTY2D1

NCBI ID: G144108

SPTY2D1

SPTY2D1: Key Regulator of Cell Growth and Differentiation

SPTY2D1 (SPT2, Suppressor of Ty, domain containing 1) is a protein that is expressed in various tissues of the human body, including the brain, heart, and blood vessels. It is a key regulator of cell growth and differentiation, and has been implicated in a number of diseases, including cancer.

SPTY2D1 is a member of the TGF-β (Transforming Growth Factor-尾) family, which is a well-known regulator of cell growth and differentiation. TGF-β signaling is involved in the development and maintenance of tissues, including organs, tissues, and organs.

SPTY2D1 is a 21-kDa protein that is expressed in various tissues of the human body. It is highly conserved, with a calculated pI of 4.77. SPTY2D1 is primarily expressed in the brain, heart, and blood vessels, and is also found in other tissues, including the pancreas, lung, and liver.

SPTY2D1 is involved in a number of cellular processes, including cell growth, differentiation, and survival. It has been shown to play a role in the regulation of cell proliferation, cell survival, and cell death.

SPTY2D1 has also been shown to be involved in the regulation of cellular signaling pathways, including the TGF-β pathway. This pathway is involved in the development and maintenance of tissues, and is a key regulator of cell growth and differentiation.

SPTY2D1 has been shown to play a role in the regulation of the Notch signaling pathway. Notch signaling is involved in the regulation of cell survival and growth, and is a key regulator of development and wound healing.

SPTY2D1 has also been shown to play a role in the regulation of the Wnt signaling pathway. Wnt signaling is involved in the regulation of cell growth and differentiation, and is a key regulator of development and wound healing.

SPTY2D1 has been shown to be involved in the regulation of the Runx/TGF-β pathway. This pathway is involved in the regulation of cell growth and differentiation, and is a key regulator of development and wound healing.

SPTY2D1 has also been shown to play a role in the regulation of the Hedgehog signaling pathway. Hedgehog signaling is involved in the regulation of cell growth and differentiation, and is a key regulator of development and wound healing.

SPTY2D1 has been shown to play a role in the regulation of the FGF-1 signaling pathway. FGF-1 signaling is involved in the regulation of cell growth and differentiation, and is a key regulator of development and wound healing.

SPTY2D1 has also been shown to play a role in the regulation of the PDGF-2 signaling pathway. PDGF-2 signaling is involved in the regulation of cell growth and differentiation, and is a key regulator of development and wound healing.

SPTY2D1 has been shown to play a role in the regulation of the SGPR2 signaling pathway. SGPR2 signaling is involved in the regulation of cell survival and growth, and is a key regulator of development and wound healing.

SPTY2D1 has also been shown to play a role in the regulation of the NF-kappa-B signaling pathway. NF-kappa-B signaling is involved in the regulation of cell growth and inflammation, and is a key regulator of development and wound healing.

SPTY2D1 has been shown to play a role in the regulation of the AP-1 signaling pathway. AP-1 signaling is involved in the regulation of cell growth and differentiation, and is a key regulator of development and wound healing.

SPTY2D1 has also been shown to play a role in the regulation of the NF-E2 signaling pathway. NF-E2 signaling is involved in the regulation of cell survival and growth, and is a key regulator of development and wound healing.

SPTY2D1 has been shown to play a role in the regulation of the

Protein Name: SPT2 Chromatin Protein Domain Containing 1

Functions: Histone chaperone that stabilizes pre-existing histone tetramers and regulates replication-independent histone exchange on chromatin (PubMed:26109053). Required for normal chromatin refolding in the coding region of transcribed genes, and for the suppression of spurious transcription (PubMed:26109053). Binds DNA and histones and promotes nucleosome assembly (in vitro) (PubMed:23378026, PubMed:26109053). Facilitates formation of tetrameric histone complexes containing histone H3 and H4 (PubMed:26109053). Modulates RNA polymerase 1-mediated transcription (By similarity). Binds DNA, with a preference for branched DNA species, such as Y-form DNA and Holliday junction DNA (PubMed:23378026)

The "SPTY2D1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SPTY2D1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets